Here, we observed an inverse correlation of IRX1 and DNMT3A or EZH2 expression in primary lung cancers suggesting a causal relation between aberrant expression of epigenetic modifiers and IRX1 silencing. This evidence concerns the gene EZH2 and lung carcinoma.